MJN
MEAD JOHNSON NUTRITION CO
MEAD JOHNSON NUTRITION CO historical holders
total: 3
Wedgewood Partners MEAD JOHNSON NUTRITION CO transactions over time
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 5
- Reduced:
- 6
- Held since:
- 2014 Q1
- Held for:
- 12 quarters
- Latest activity:
- 2017 Q1
David Rolfe has been an institutional investor in MEAD JOHNSON NUTRITION CO (MJN) since 2014 Q1. According to 2026 Q1 report, David Rolfe doesn't hold any shares. The fund/company first acquired MJN in 2014 Q1, initially purchasing about 2.32M shares. Since the initial investment, Wedgewood Partners has made 12 more transactions in this position.
When did David Rolfe exit their MJN position?
David Rolfe no longer holds MEAD JOHNSON NUTRITION CO (MJN). They sold off their entire position in 2017 Q1, closing out an investment that began in 2014 Q1.
When did David Rolfe first invest in MJN?
David Rolfe first invested in MEAD JOHNSON NUTRITION CO (MJN) in 2014 Q1 at the reported quarter-end price of $83.14 per share, acquiring 2,315,336 shares in their initial purchase.
What is David Rolfe's average cost basis for MJN?
Based on historical transaction data, David Rolfe's estimated cost basis for MEAD JOHNSON NUTRITION CO (MJN) is approximately $81.97 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $81.97
- Weighted AVG sell price:
- $76.51
MJN transactions history by Wedgewood Partners
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2017 Q1
|
0.00%
|
$70.76
|
-100% (-1,451,913)
|
|||
|
2016 Q4
|
2.51%
|
$70.76
|
-15.29% (-262,106)
|
|||
|
2016 Q3
|
2.84%
|
$79.01
|
-33.66% (-869,701)
|
|||
|
2016 Q2
|
4.75%
|
$90.75
|
-9.66% (-276,164)
|
|||
|
2016 Q1
|
4.41%
|
$84.97
|
-8.85% (-277,738)
|
|||
|
2015 Q4
|
4.25%
|
$78.95
|
-10.28% (-359,539)
|
|||
|
2015 Q3
|
3.58%
|
$70.40
|
+28.09% (+767,009)
|
|||
|
2015 Q2
|
3.30%
|
$90.22
|
+5.24% (+135,986)
|
|||
|
2015 Q1
|
3.50%
|
$100.53
|
-0.83% (-21,626)
|
|||
|
2014 Q4
|
3.55%
|
$100.54
|
+9.26% (+221,677)
|
|||
|
2014 Q3
|
3.72%
|
$96.22
|
+0.52% (+12,270)
|
|||
|
2014 Q2
|
3.87%
|
$93.17
|
+2.87% (+66,509)
|
|||
|
2014 Q1
|
3.56%
|
$83.14
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.